Blogopmaak
Developing genetic treatments for patients with very rare mutations
Annemieke Aartsma-Rus published an article about DCRT in Nature Medicine! In this article Annemieke tells about "N of 1" therapies, RNA therapies that are only suitable for one patient. DCRT is developing individualized ASOs for
patients with genetic brain or eye disorders and Annemieke summarizes the challenges that we face in these studies.
To read the whole article, go to Nature Medicine Worldview of 24th of May 2021.
published on May 25, 2021
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam